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Background: Diabetes mellitus (DM) is one of the most frequent etiologies of erectile dysfunction (ED).
Risk factors of ED in type 2 diabetes mellitus (T2 DM) include patient age, disease duration, sedentary life
and glycemic control. Subnormal testosterone concentrations contribute to ED as testosterone regulates
nearly every component of erectile function.
The aim of the work was to study the age of the patient, duration of diabetes mellitus, body mass index
(BMI), glycosylated hemoglobin (HbAIc) and urinary albumin creatinine ratio (uACR) in type 2 male dia-
betic patients as risk factors for erectile dysfunction and their relation to serum testosterone level.
Patients and methods: This study was conducted on 100 male type 2 diabetics selected from inpatient
department and out patient clinics of the Internal Medicine Department in Menoufia University Hospital.
The patients were divided into two groups: Group 1: 50 patients with type 2 DMwith erectile dysfunction
and Group 2: 50 patientswith type 2 DMwithout erectile dysfunction. The study groups were subjected to
thorough history with special emphasis on age of the patients, disease duration and investigations includ-
ing testosterone level, glycosylated hemoglobin, and uACR. The patients answered the abridged 5-itemver-
sion of the International Index of Eectile Function (IIEF-5) questionnaire.
Results: Total serum testosterone was significantly lower in diabetics with ED compared to those without
ED. HbAIc, diabetes duration and uACR were independently negatively correlated with testosterone level.
Conclusion: The diabetes duration, glycemic control and uACR contribute to erectile dysfunction in type 2
diabetics, and they were independently and negatively correlated with total serum testosterone level.
 2018 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction 2. Patients and methodsThe long term complications of diabetes include dysfunction of
different organs and sexual dysfunction.1
ED is defined as the persistent inability to achieve or maintain
penile erection sufficient for satisfactory sexual performance.2 Per-
sistence of ED over 3 months has been suggested as a reasonable
clinical guideline.3
There are a lot of risk factors for ED in diabetic patients.4 Sub-
normal testosterone levels were found in diabetic men and con-
tribute to ED.5
This study was designed to study the patient’s age, diabetes
duration, HbA1c, uACR and BMI as risk factors for ED in type 2 male
diabetics and their correlation to serum testosterone level.This study was conducted on 100 male type 2 diabetic patients
aged above 40 years and with duration of diabetes more than 5
years. The patients selected from inpatient and outpatient clinics
of the Internal Medicine department in Menoufia University. The
protocol of the study was approved by the ethical committee of
Faculty of Medicine. The selected patients gave consent for partic-
ipation in the study before they were exposed to examination and
investigations. The study was done from June 2017 to August 2017.
The diabetic patients were divided into two groups:
Group 1: 50 male patients with type 2 diabetes with erectile
dysfunction.
Group 2: 50 male patients with type 2 diabetes without erectile
dysfunction.
Exclusion criteria included advanced liver or renal diseases,
malignancy, use of medications that cause hypogonadism or those
Table 1
Comparison between the studied groups according to demographic and laboratory data.
Parameter Group 1 (n = 50) Group 2 (n = 50) Test of significance P
Age (years) 53.54 ± 5.61 49.51 ± 7.32 t = 3.09 *.002
Duration of diabetes (years) 9.49 ± 3.20 7.06 ± 2.82 Mw = 2.83 *.005
Body mass index (kg/m2) 32.39 ± 5.4 28.70 ± 5.13 t = 3.503 .001
Glycated hemoglobin (%) 10.20 ± 2.37 8.30 ± 1.70 t = 4.606 *<.001
Urinary albumin creatinine ratio (mg/g/cr) 480.20 ± 118 26.35 ± 90.35 Mw = 9.021 *<.001
Total serum testosterone (ng/dl) 194 ± 107.65 453 ± 101.37 Mw = 8.031 *<.001
Mw: Value for Mannwhitney test t: student test.
* Statistically significant at P  .05.
Table 2




Age (years) 0.091 .490
Duration of diabetes (years) 0.402 *.001
Body mass index (kg/m2) 0.316 *.014
Glycated hemoglobin (%) 0.333 *.009
Urinary albumin creatinine ratio (mg/g/cr) 0.925 *<.001
rs: Spearman Coefficient.
* Statistically significant at P  .05.
Table 3
Linear regression for the studied parameters affecting total serum testosterone.
Parameter Total Serum testosterone
(ng/dl)
B SE P
Age (years) 0.049 0.056 .509
Duration of diabetes (years) 27.430 12.87 *.036
Body mass index (kg/m2) 0.619 0.50 .240
Glycated hemoglobin (%) 0.076 0.018 *.004
Urinary albumin creatinine ratio (mg/g/cr) 0.080 0.002 *.002
B: Unstandardized coefficient.
SE: Stander error.
* Statistically significant at P  .05.
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trauma and surgery.
Patients of the study were subjected to thorough history taking
with special emphasis on the age, duration of diabetes mellitus and
detailed drug history. Complete physical examination was done
including weight and height to calculate body mass index.
Investigations included liver profile, complete blood picture,
glycosylated hemoglobin, blood urea and creatinine, complete
urine analysis, urine albumin creatinine ratio and total serum
testosterone level were done.
The patients were asked to answer the abridged 5 – item ver-
sion of the International Index of Erectile Function (IIEF-5) ques-
tionnaire.6 This questionnaire consists of 5 questions each of
them is scored on five – point ordinal score where the lower values
represent poor erectile function. Patients with score less than 22
were considered to have erectile dysfunction.7 All patients filled
the Arabic version of IIEF-5 questionnaire by themselves.3. Statistical methodology
Data were analyzed using Statistical Package for Social Science
(SPSS) software computer program version 15, (IBM Corp, IBM
SPSS Statistics for Windows, Version 15.0 Armonk, NY:IBM Corp.
Chicago, USA) Quantitative data were described using mean and
standard deviation. Significance level (P) value was P less than or
equal to 0.05.4. Results
The mean age, Glycosylated hemoglobin, BMI and uACR were
statistically significantly higher in group 1 compared with group
2. Total Serum testosterone level was statistically significantly
lower in group 1 compared with group 2 (Table 1). Total serum
testosterone level was significantly negatively correlated with
the duration of diabetes, HbAIc, BMI and uACR (Table 2).
Only duration of diabetes, HbAIc and uACR were independently
negatively correlated with total serum testosterone level (Table 3).5. Discussion
Diabetes mellitus is a major health problem worldwide. The
association between hypogonadism and diabetes mellitus has
recently received substantial attention.8
The present study reported that the age of the patients with ED
was significantly higher than the age of those without ED. The is
similar to cross sectional study by Giuliano et al.9 on population
of 7689 patients in Italy [including 3563 patients with DM] con-
firmed the relation between increasing age and increasing preva-
lence of ED. The same results obtained from other studies.10,11
On the other hand, studies conducted by Ghazi et al.8 and
Romeo et al.12 did not consider age as a risk factor for ED.
The result of the current study showed that diabetic patients
with ED had significantly longer duration of diabetes when com-
pared to those without ED and that total testosterone level was
independently negatively correlated with the duration of diabetes.
This is in agreement with an observational study on total of 5477
Chinese men with type 2 DM by Yang et al.13 found that the dura-
tion of DM was significantly associated with the presence and
severity of ED.
Comparably, a study on 3980 diabetic men aged 30–69 years
was performed by Selim et al.14 reported that the frequency of
ED increased with duration of DM, ranging from 44.6% for DM last-
ing <5 years to 88.9% for DM > 20 years and that patients with ED
had a longer duration of DM than those without ED.
Similar to our study, Al Hayek et al.15 and Corona et al.16 reported
that the prevalence of low testosteronewashigher in patientswith a
longer duration of DM. Also, another study on 123men with T2 DM
by shaheen et al.17 showed a negative correlation between serum
testosterone and duration of diabetes. On the other hand Dhindsa
et al.1 andMirzae et al.19 reportedno significant correlationbetween
hypogonadism and duration of diabetes.
In the present study group 1 patients had significantly higher
BMI than group 2 patients. Also there was a significant negative
correlation between BMI and testosterone level. A large study on
ED, the Health Professionals Follow up Study [HPF5] which
included 22,086 United States men from 40 to 75 years old has
found BMI was inversely associated with the risk of ED develop-
ment.20 Another study by Hofstra et al.21 on 160 obese men, the
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obesity had low serum testosterone.
The results of our study showed that patients with ED had
significantly higher HbAIc when compared to patients without
ED and HbAIc was found to be independently negatively correlated
with testosterone level. These results in agreement with a study by
Rabijewski et al.22 reported significant negative correlation
between HbA1c and testosterone concentration in type 2 DM.
Moreover Aboelanga and ElShaway.23 reported that HbAIc was a
significant predictor for total testosterone in type 2 diabetic
patients and risk factor for male hypogonadism.
Chronic hyperglycemia induces derangement on vascular and
neuronal cells including hemodynamic alteration, endothelial dys-
function, accumulation of advanced glycated end products and
activation of inflammatory cells either by generating toxic and
reactive metabolites or altering intracellular signaling pathways
which can suppress release of pituitary gonadotrophins in states
of hyperglycemia.24
In our study uACR was significantly higher in group 1 compared
to group 2 and it was independently statistically significantly neg-
atively correlated with total serum testosterone. In agreement
with the results reported by Chuang et al.25 who conducted a study
on 455 patients to evaluate the association of albuminuria as a risk
factor for ED in men with T2 DM. They found that albuminuria was
an important risk factor for ED in men with diabetes after adjust-
ment of age and diabetes mellitus duration. Similarly Yu et al.26
in a study conducted on 313 patients with T2 DM have also
reported higher prevalence of albuminuria and that higher uACR
associated with ED severity.
The explanation of this relation between hypogonadism and
albuminuria is not well established. However, albuminuria is con-
sidered as a marker of vascular endothelial damage and chronic
low grade inflammation.27 It is postulated that albuminuria might
be a marker for microvascular affection of hypothalamus in dia-
betic patients which will lead to disturbed release of gonadotropic
releasing hormones causing hypogonadism.23
The present study showed that patients with ED had signifi-
cantly lower total serum testosterone levels than those without
ED. In agreement with the results reported by Ghazi et al.8 who
found that 94% of type 2 diabetic patients with low serum
testosterone had ED versus 61% for the patients with normal serum
testosterone. Similarly, El Saghier et al.28 reported that patients
with ED had lower testosterone than those without ED and that
85.7% of T2 DM patients with low serum testosterone had ED
versus 31% of those with normal testosterone.
This hypogonadal state may be due to hypogonadotrophic
hypogonadism which is mostly secondary to chronic disease such
as T2 DM which could be associated with impaired function of
hypothalamic Pituitary testicular axis.18
6. Conclusion
Type 2 diabetic patients with erectile dysfunction have high
prevalence of low serum testosterone level which significantly
negatively correlated with duration of diabetes, HbAIc and uACR.
So such risk factors should be considered and may play an
important role in erectile dysfunction in type 2 diabetic patients.
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